WEBSep 23, 2021 · Among U.S. adults without immunocompromising conditions, vaccine effectiveness against COVID-19 hospitalization during March 11–August 15, 2021, was higher for the Moderna vaccine (93%) than the Pfizer-BioNTech vaccine (88%) and the Janssen vaccine (71%).
DA:76PA:97MOZ Rank:99
Comparing the differences between COVID-19 vaccines
WEBModerna Approval, authorization and safety. 2023-2024 Moderna vaccine is authorized for people ages 6 months through 11 years. Spikevax is approved for people age 12 and older. The vaccines that help protect against COVID-19 are safe and effective based on clinical trials and continued monitoring.
DA:92PA:29MOZ Rank:19
Moderna vs. Pfizer: Both Knockouts, but One Seems to Have the …
WEBSep 22, 2021 · The Pfizer-BioNTech and Moderna vaccines rely on the same mRNA platform, and in the initial clinical trials, they had remarkably similar efficacy against symptomatic infection: 95 percent for...
DA:74PA:47MOZ Rank:97
Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against …
WEBMay 6, 2021 · In U.S. hospitals during January–March 2021, receipt of Pfizer-BioNTech or Moderna COVID-19 vaccines was 94% effective against COVID-19 hospitalization among fully vaccinated adults and 64% effective among partially vaccinated adults aged ≥65 years.
DA:82PA:48MOZ Rank:60
The Moderna COVID-19 (mRNA-1273) vaccine: what you need to …
WEBThe Moderna vaccine after two doses and a first booster dose has been shown to have very high effectiveness against severe disease, hospitalizations and death, and modest effectiveness against symptomatic illness.
DA:64PA:74MOZ Rank:19
Sustained Effectiveness of Pfizer-BioNTech and Moderna …
WEBAug 26, 2021 · Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults — United States, March–July 2021. Weekly / August 27, 2021 / 70 (34);1156-1162. On August 18, 2021, this report was posted online as an MMWR Early Release.
DA:22PA:90MOZ Rank:81
Get the facts about COVID-19 vaccines - Mayo Clinic
WEBNov 3, 2023 · In December 2020, the Moderna COVID-19 vaccine was found to be both safe and about 93% effective in preventing infection among study volunteers, all age 18 or older. Based on the comparison between people who got COVID-19 in the placebo group, the Moderna COVID-19 vaccine was 98% effective at preventing serious COVID-19 illness.
DA:58PA:18MOZ Rank:3
Peer-reviewed report on Moderna COVID-19 vaccine publishes
WEBDec 30, 2020 · The investigational vaccine known as mRNA-1273 was 94.1% efficacious in preventing symptomatic coronavirus disease 2019 (COVID-19), according to preliminary results from a Phase 3 clinical trial reported in the New England Journal of Medicine. The vaccine also demonstrated efficacy in preventing severe COVID-19.
DA:83PA:36MOZ Rank:71
Effectiveness of mRNA Covid-19 Vaccine among U.S. Health …
WEBSep 22, 2021 · Vaccine effectiveness for partial vaccination was 77.6% (95% confidence interval [CI], 70.9 to 82.7) with the BNT162b2 vaccine (Pfizer–BioNTech) and 88.9% (95% CI, 78.7 to 94.2) with the...
DA:38PA:73MOZ Rank:8
Moderna COVID-19 vaccine generates long-lasting immune memory
WEBThe Moderna and Pfizer mRNA vaccines against COVID-19 have shown greater than 90% effectiveness soon after the second dose. Studies suggest that protective immunity remains high, with only slight decreases, over six months.